Immunosuppressive agents.
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000917:Antibody Formation / Q000187:drug effects; D000963:Antimetabolites / Q000494:pharmacology; D001215:Asparaginase / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004285:Dogs; D005493:Folic Acid Antagonists / Q000494:pharmacology; D005972:Glutaminase / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007108:Immune Tolerance / Q000187:drug effects; D007114:Immunization; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D051379:Mice; D010206:Papain / Q000494:pharmacology; D014176:Protein Biosynthesis; D011687:Purines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000187:drug effects / Q000276:immunology
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D011687:Purines; D011743:Pyrimidines; D012313:RNA; D003520:Cyclophosphamide; D004247:DNA; D010206:Papain; D001215:Asparaginase; D005972:Glutaminase